Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for AbCellera, Canva, and 370+ companies. 5-min read every Tuesday.
Antibody discovery platform using AI and microfluidics to rapidly identify therapeutic antibodies at scale.
| Industry | Biotechnology |
| Stage | Public |
| IPO Status | Public |
| Valuation | $1.2B |
| Total Funding | $105M |
| Headquarters | Vancouver, BC, Canada |
Canva is the world's leading design platform with 250M+ users — valued at $48B with $770M raised. Track IPO timeline, funding rounds, and readiness score.
| Industry | Design & Creative |
| Stage | Pre-IPO |
| IPO Status | Private |
| Valuation | $42B |
| Total Funding | $770M |
| Headquarters | Sydney, Australia |
AbCellera is valued at $1.2B. Canva is valued at $42B. Both valuations are based on the most recent private funding rounds tracked by TechStackIPO.
AbCellera has raised $105M. Canva has raised $770M.
AbCellera is currently already public. Canva is currently private. Track both on TechStackIPO for S-1 filings and IPO announcements.
AbCellera operates in Biotechnology, while Canva operates in Design & Creative.
AbCellera is a Biotechnology company valued at $1.2B with $105M raised. Canva is a Design & Creative company valued at $42B with $770M raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor data.
Accredited investors can access pre-IPO shares in AbCellera and Canva through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.